ICM
EMN icon

Invenomic Capital Management’s Eastman Chemical EMN Stock Holding History

Invenomic Capital Management’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.24M Sell
48,307
-10,936
-18% -$800K 0.19% 93
2026
Q1 		$4.52M Sell
59,243
-217,980
-79% -$15.7M 0.21% 109
2025
Q4 		$17.7M Buy
277,223
+145,533
+111% +$8.97M 0.82% 44
2025
Q3 		$8.3M Buy
131,690
+71,794
+120% +$5.01M 0.4% 81
2025
Q2 		$4.47M Buy
59,896
+32,768
+121% +$2.57M 0.25% 104
2025
Q1 		$2.39M Sell
27,128
-7,660
-22% -$723K 0.12% 148
2024
Q4 		$3.18M Sell
34,788
-9,562
-22% -$981K 0.15% 131
2024
Q3 		$4.96M Sell
44,350
-138,873
-76% -$13.9M 0.27% 100
2024
Q2 		$18M Buy
183,223
+3,813
+2% +$378K 0.87% 39
2024
Q1 		$18M Buy
179,410
+53,143
+42% +$4.67M 0.96% 37
2023
Q4 		$11.3M Sell
126,267
-27,175
-18% -$2.17M 0.52% 67
2023
Q3 		$11.8M Sell
153,442
-5,278
-3% -$438K 0.49% 62
2023
Q2 		$13.3M Sell
158,720
-13,536
-8% -$1.1M 0.67% 48
2023
Q1 		$14.5M Buy
172,256
+78,750
+84% +$6.76M 0.82% 40
2022
Q4 		$7.62M Buy
93,506
+38,737
+71% +$3.12M 0.52% 65
2022
Q3 		$3.89M Buy
+54,769
New +$4.92M 0.33% 89
2020
Q4 		– Sell
-8,862
Closed -$692K – 152
2020
Q3 		$692K Sell
8,862
-24,165
-73% -$1.82M 0.38% 78
2020
Q2 		$2.3M Sell
33,027
-4,514
-12% -$284K 1.7% 11
2020
Q1 		$1.75M Sell
37,541
-31,485
-46% -$2.02M 1.43% 20
2019
Q4 		$5.47M Buy
+69,026
New +$5.31M 2.2% 8

Other funds holding EMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Invenomic Capital Management's EMN Position: Q2 2026 in Review

Invenomic Capital Management reduced its Eastman Chemical (EMN) stake by 18% in Q2 2026, selling an estimated $800K and leaving 48,307 shares worth $3.24M. The position accounts for 0.19% of the portfolio, ranked #93.

Invenomic Capital Management first reported a position in EMN in Q4 2019 and has held it in 20 quarters since. The position peaked at $18M in Q1 2024. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Invenomic Capital Management held 48,307 shares of Eastman Chemical worth $3.24M as of Q2 2026.
  • Invenomic Capital Management sold 10,936 Eastman Chemical shares in Q2 2026, an estimated $800K.
  • Eastman Chemical made up 0.19% of Invenomic Capital Management's portfolio in Q2 2026, its #93 holding.
  • Invenomic Capital Management first reported a position in Eastman Chemical in Q4 2019 and has held it in 20 quarters since.
  • Invenomic Capital Management's Eastman Chemical position peaked at $18M in Q1 2024.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.